$IDXG 4/A SEC Filings

Filed On	Filing
10 Feb 2020	Form 4/A: Richard Gregory, Chief Commercial Officer Holds 8,503 shares of Common Stock
10 Feb 2020	Form 4/A: Stover Jack E, Director Holds 23,083 shares of Common Stock
08 Mar 2019	Form 4/A: Stover Jack E, Director Received 87,000 shares as a grant or award · Granted 348,000 Stock Option (right to buy)
08 Mar 2019	Form 4/A: Early James, Chief Financial Officer Received 3,000 shares as a grant or award · Granted 12,000 Stock Option (right to buy)
08 Mar 2019	Form 4/A: Richard Gregory, Chief Commerical Officer Received 13,400 shares as a grant or award · Granted 53,600 Stock Option (right to buy)
11 Jun 2015	Form 4/A: Belle Gerald P., Director Received 45,455 shares as a grant or award ($60K)
12 Nov 2014	Form 4/A: Melillo Gerald R Jr, President, Sales Services Bought 5,000 shares ($7.9K)
21 Nov 2008	Form 4/A: Ryan Frank J, Director Acquired 2,941 shares (Other Transaction)
30 Jun 2008	Form 4/A: Connolly Kevin, EVP, Marketing Services Holds 32,415 shares of Common Stock
30 Jun 2008	Form 4/A: McCarthy Nancy, EVP, Human Resources Holds 20,523 shares of Common Stock
11 Jun 2008	Form 4/A: Marquard Michael, CEO Acquired 11,244 shares (Other Transaction)
03 Jun 2008	Form 4/A: Smith Jeffrey Edward, CFO Acquired 7,424 shares (Other Transaction)
03 Jun 2008	Form 4/A: Pietruski John M, Director Acquired 4,411 shares (Other Transaction)
03 Jun 2008	Form 4/A: Federspiel John, Director Acquired 4,411 shares (Other Transaction)
03 Jun 2008	Form 4/A: Vecsi Jan Martens, Director Acquired 4,411 shares (Other Transaction)
02 Dec 2005	Form 4/A: Ellberger Larry, Chief Executive Officer Granted 7,500 Stock Option
27 Apr 2004	Form 4/A: Pdi Inc, Director · Celldex Therapeutics, Inc. Granted 10,000 Non-Qualified Stock Option ($27.6K)

Comments